Date of Award
Master of Arts (MA)
Claudin low triple negative breast cancer (TNBC) has the worst clinical outcomes in comparison to other breast cancer subtypes. The underlying molecular mechanisms associated with the aberrant expression of claudins are not well understood. The transcript from PVT1 exon 9 is a regulator of claudin expression, and migration, in TNBC.
Levine, Fayola, "PVT1 exon 9 a regulator of claudin expression in triple negative breast cancer" (2020). CUNY Academic Works.